Literature DB >> 15094052

Inhibition of insulin amyloid formation by small stress molecules.

Anubhav Arora1, Chanki Ha, Chan Beum Park.   

Abstract

Amyloidogenic proteins undergo an alternative folding pathway under stressful conditions leading to formation of fibrils having cross beta-sheet structure, which is the hallmark of many neurodegenerative diseases. As a means of surviving against external stress, on the other hand, many microorganisms accumulate small stress molecules to prevent abnormal protein folding and to contribute to protein stability, which hints at the efficacy of the solutes against amyloid formation. The current work demonstrates the effectiveness of small stress molecules such as ectoine, betaine, trehalose, and citrulline on inhibition of insulin amyloid formation in vitro. The inhibitory effects were analyzed by thioflavin T-induced fluorescence, circular dichroism, and atomic force microscopy. This report suggests that naturally occurring small molecules may serve a function that is typically fulfilled by protein chaperones, and it provides a hint for designing inhibitors against amyloid formation associated with neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094052     DOI: 10.1016/S0014-5793(04)00326-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  41 in total

1.  Inhibition of insulin fibrillogenesis with targeted peptides.

Authors:  Todd J Gibson; Regina M Murphy
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

2.  Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin.

Authors:  Sheldon Park; Jeffery G Saven
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

3.  Two disaccharides and trimethylamine N-oxide affect Abeta aggregation differently, but all attenuate oligomer-induced membrane permeability.

Authors:  Wei Qi; Aming Zhang; Theresa A Good; Erik J Fernandez
Journal:  Biochemistry       Date:  2009-09-22       Impact factor: 3.162

Review 4.  Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease.

Authors:  Masoomeh Khalifeh; George E Barreto; Amirhossein Sahebkar
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

Review 5.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

6.  Inhibition of Alzheimer amyloid β aggregation by polyvalent trehalose.

Authors:  Yoshiko Miura; Chouga You; Reiko Ohnishi
Journal:  Sci Technol Adv Mater       Date:  2008-07-24       Impact factor: 8.090

Review 7.  Suppression and dissolution of amyloid aggregates using ionic liquids.

Authors:  Takahiro Takekiyo; Yukihiro Yoshimura
Journal:  Biophys Rev       Date:  2018-04-25

8.  The natural osmolyte trehalose is a positive regulator of the heat-induced activity of yeast heat shock transcription factor.

Authors:  Laura K Conlin; Hillary C M Nelson
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

9.  Mechanism for retardation of amyloid fibril formation by sugars in Vλ6 protein.

Authors:  Masahiro Abe; Yoshito Abe; Takatoshi Ohkuri; Tomonori Mishima; Akira Monji; Shigenobu Kanba; Tadashi Ueda
Journal:  Protein Sci       Date:  2013-02-21       Impact factor: 6.725

10.  Protective effect of 3,5,3'-triiodothyroacetic and 3,5,3',5'-tetraiodothyroacetic acids on serum albumin fibrillation.

Authors:  Leonardo M Cortez; Ricardo N Farías; Rosana N Chehín
Journal:  Eur Biophys J       Date:  2009-04-18       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.